Sink condition
Sink condition is a term used in pharmacology and drug development to describe a specific set of circumstances during in vitro dissolution testing of pharmaceutical dosage forms. The sink condition is achieved when the medium's capacity to dissolve the drug substance is significantly higher than the concentration of the drug in the dosage form. This ensures that the dissolution rate is not limited by the solubility of the drug, but rather by the characteristics of the dosage form itself.
Overview[edit]
The concept of sink condition is crucial in the field of pharmaceutical sciences, particularly in the development and testing of oral dosage forms. It is used to simulate the conditions in the gastrointestinal tract where the drug is expected to dissolve and be absorbed into the body.
The sink condition is defined as a volume of dissolution medium that is at least three times the saturation solubility of the drug. This ensures that the drug concentration in the medium does not exceed 30% of its saturation solubility, allowing for a constant dissolution rate.
Importance[edit]
Achieving sink conditions in dissolution testing is important for several reasons. Firstly, it ensures that the dissolution rate is representative of the rate at which the drug will dissolve in the body. Secondly, it allows for the detection of changes in the formulation that may affect the dissolution rate. Lastly, it provides a consistent and reproducible method for testing the dissolution rate of different formulations.
Challenges[edit]
While the concept of sink condition is straightforward, achieving it in practice can be challenging. This is because the solubility of the drug in the dissolution medium can be affected by several factors, including the pH of the medium, the presence of surfactants, and the temperature at which the test is conducted.
Furthermore, some drugs have low solubility in water, making it difficult to achieve sink conditions. In such cases, alternative methods such as the use of surfactants or cosolvents may be employed to increase the solubility of the drug.
See also[edit]
References[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
